Dr. Arielle Lutterman Heeke, MD

Dr. Heeke practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Heeke's NPI, 1881950848, was assigned on April 4, 2012. Dr. Heeke graduated from Emory School of Medicine in 2012. Dr. Heeke holds North Carolina license 2018-01243.

Dr. Heeke's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Heeke's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Heeke is also affiliated with Atrium Health Pineville. The medical group on file is Atrium Health Levine Cancer Institute. Dmand AI also links Dr. Heeke to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heeke practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Heeke's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Heeke is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Heeke's licenses on file in 4 states: North Carolina, South Carolina, District of Columbia and Georgia.

Dmand AI lists breast cancer and chronic anemia among the conditions Dr. Heeke treats.

CMS data shows 363 Medicare services from Dr. Heeke across 4 procedure codes in 2024, for 111 Medicare patients. Medicare paid $21,460 for them.

CMS counts 111 Medicare patients who saw Dr. Heeke in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have cancer, and 63% have high cholesterol. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Heeke's median patient age at 70, with 87% women.

In 2024, Dr. Heeke wrote 665 Medicare Part D claims for 156 patients. 81% of them were for generic drugs. CMS names the drug for 483 of them, across 12 drugs with 11 or more claims each, at $1,178,628 in total drug cost. In 2023, CMS named 524 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Heeke for performance year 2024, reported as part of a group. Dr. Heeke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Heeke as offering telehealth.

Dmand AI links 16 papers to Dr. Heeke, published from 2018 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Anti-Bacterial Agents. Dr. Heeke has published most often in JCO Precis Oncol. Dr. Heeke's most frequent co-authors are Antoinette Roslyn Tan, MD, Paula Raffin Pohlmann, MD and Wolfgang Michael Korn, MD.

Dmand AI links Dr. Heeke to 5 clinical trials. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Triple Negative Breast Neoplasms. Georgetown University sponsors the most, 2.

CMS Open Payments shows 94 general payments to Dr. Heeke from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Daiichi Sankyo Inc. paid the most, $22,395.

Dr. Heeke graduated from Emory School of Medicine in 2012.

Dr. Heeke is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.